NFKB1 and neoplasm: Furthermore, PTGDR2 exerts anti-inflammatory and anti-tumor effects by inhibiting the classical NF-κB signaling pathway as well as KRAS, MAPK, ERK1/2, and Akt-mediated transcription factor signaling pathways [48–51].